Your browser doesn't support javascript.
loading
Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.
Vaduganathan, Muthiah; Greene, Stephen J; Zhang, Shuaiqi; Solomon, Nicole; Chiswell, Karen; Devore, Adam D; Butler, Javed; Heidenreich, Paul A; Huang, Joanna C; Kittleson, Michelle M; Joynt Maddox, Karen E; Mcdermott, James J; Owens, Anjali Tiku; Peterson, Pamela N; Solomon, Scott D; Vardeny, Orly; Yancy, Clyde W; Fonarow, Gregg C.
Afiliación
  • Vaduganathan M; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Greene SJ; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
  • Zhang S; Duke Clinical Research Institute, Durham, North Carolina.
  • Solomon N; Duke Clinical Research Institute, Durham, North Carolina.
  • Chiswell K; Duke Clinical Research Institute, Durham, North Carolina.
  • Devore AD; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
  • Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.
  • Heidenreich PA; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
  • Huang JC; AstraZeneca, Wilmington, Delaware.
  • Kittleson MM; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai, Los Angeles, California.
  • Joynt Maddox KE; Department of Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri.
  • Mcdermott JJ; AstraZeneca, Wilmington, Delaware.
  • Owens AT; Heart and Vascular Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Peterson PN; Department of Medicine, Denver Health Medical Center, Denver, Colorado; Department of Medicine, Anschutz Medical Center, Aurora, Colorado.
  • Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Vardeny O; Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, University of Minnesota, Minneapolis, Minnesota.
  • Yancy CW; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinis.
  • Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, Los Angeles, California. Electronic address: gfonarow@mednet.ucla.edu.
J Card Fail ; 28(4): 554-563, 2022 04.
Article en En | MEDLINE | ID: mdl-34785402
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Guideline Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Guideline Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article